Sage Therapeutics to Report Third Quarter 2023 Financial Results on Tuesday, November 7, 2023
24 10월 2023 - 7:30PM
Business Wire
Sage Therapeutics, Inc. (Nasdaq: SAGE), a biopharmaceutical
company leading the way to create a world with better brain health,
announced today that it will host a live webcast on Tuesday,
November 7, 2023 at 8:00 a.m. ET to review third quarter 2023
financial results and discuss recent business updates.
The webcast can be accessed on the Investor page of Sage’s
website at investor.sagerx.com. A replay of the webcast will be
available following the completion of the event and will be
archived for up to 30 days.
About Sage Therapeutics
Sage Therapeutics is a biopharmaceutical company fearlessly
leading the way to create a world with better brain health. Our
mission is to pioneer solutions to deliver life-changing brain
health medicines, so every person can thrive. For more information,
please visit www.sagerx.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20231024843423/en/
Investor Contact Ashley Kaplowitz 786-252-1419
ashley.kaplowitz@sagerx.com Media Contact Matthew Henson
917-930-7147 matthew.henson@sagerx.com
Sage Therapeutics (NASDAQ:SAGE)
과거 데이터 주식 차트
부터 4월(4) 2024 으로 5월(5) 2024
Sage Therapeutics (NASDAQ:SAGE)
과거 데이터 주식 차트
부터 5월(5) 2023 으로 5월(5) 2024
